SEC 13F Intelligence

Managers / Q2 2024

Kopp LeRoy CNEW FILER

CIK 0001399913

Reported Value
$175M
Q2 2024
Positions
21
Filings on Record
1
2019–present window
Filed
Jun 3, 2024
original filing

Summary

Kopp Leroy C reported $175M in U.S.-listed holdings across 21 positions for Q2 2024.

Its largest position, VEA, represents 17.7% of the portfolio.

Portfolio Metrics

Top-10 Concentration
+92.5%
share of reported value
Largest Position
+17.7%
Vanguard Tax Managed Fds

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q2 ’24: $175MQ2 ’24filingsflow.com

Portfolio Composition

By security type
Common Stock: 50.5%ETP: 44.0%Other: 5.5%
  • Common Stock · 50.5% · $88M
  • ETP · 44.0% · $77M
  • Other · 5.5% · $10M

Quarter-over-Quarter Changes full breakdown →

IssuerMoveShare ΔShares nowValue ΔValue now
VEAVANGUARD TAX-MANAGED FDSNEW+618.9K618.9K+$31M$31M
IWMISHARES TRNEW+106.3K106.3K+$29M$29M
VCELVericel CorporationNEW+457.6K457.6K+$24M$24M
VWOVANGUARD INTL EQUITY INDEX FNEW+400.5K400.5K+$17M$17M
FIVNFive9 IncNEW+237.5K237.5K+$15M$15M
NEONeoGenomics IncNEW+894.5K894.5K+$14M$14M
Atlassian Corp PLCNEW+49.7K49.7K+$10M$10M
INSPInspire Med Sys IncNEW+41.1K41.1K+$9M$9M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

13 positions
#IssuerClass% PortfolioValueShares
1VEAVANGUARD TAX-MANAGED FDShistory →VAN FTSE DEV MKT17.73%$31M618.9K
2IWMISHARES TRRUSSELL 2000 ETF · CORE MSCI EAFE · CORE S&P500 ETF · CORE 1 5 YR USD · CORE MSCI EMKT · CORE INTL AGGR · CR 5 10 YR ETF · CORE S&P MCP ETF · CORE S&P SCP ETF16.71%$29M113.4K
3VCELVericel Corporationhistory →COM13.60%$24M457.6K
4VWOVANGUARD INTL EQUITY INDEX Fhistory →FTSE EMR MKT ETF9.56%$17M400.5K
5FIVNFive9 Inchistory →COM8.43%$15M237.5K
6NEONeoGenomics Inchistory →COM NEW8.03%$14M894.5K
7Atlassian Corp PLCCL A5.54%$10M49.7K
8INSPInspire Med Sys Inchistory →COM5.04%$9M41.1K
9JAMFJAMF HOLDING CORPhistory →COM4.22%$7M402.5K
10WKWorkiva Inchistory →COM CL A3.70%$6M76.4K
11Model N IncCOM3.49%$6M214.5K
12VRDNViridian Therapeutics Inchistory →COM2.06%$4M205.6K
13MITKMITEK SYS INChistory →COM NEW1.91%$3M236.9K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q2 2024$175M21Jun 3, 202413F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.